CPO301

· Conjupro Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CPO301, covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors [Phase 1]